Eran Ovadya

Financieel Directeur/CFO bij NUREXONE BIOLOGIC INC.

Vermogen: 198 475 $ op 30-04-2024

Health Technology

Actieve functies van Eran Ovadya

Bedrijven	Functie	Begin	Einde
NUREXONE BIOLOGIC INC.	Financieel Directeur/CFO	15-06-2022	-

Bedrijven	Functie	Begin	Einde
VVT Medical Ltd.	Financieel Directeur/CFO	-	-
Silexion Therapeutics Ltd. Silexion Therapeutics Ltd. BiotechnologyHealth Technology Silenseed Ltd. operates as a biopharmaceutical company. Its programs include SiG12D-LODER for pancreatic cancer, and Prostate-LODER, GBM-LODER for brain cancer. The company was founded by Dr. Amotz Shemi and Prof. Eithan Galun on November 30, 2008 and is headquartered in Modi’in, Israel.	Financieel Directeur/CFO	-	-

Internationaal

Israël	3
Canada	2

Operationeel

Director of Finance/CFO

Sectoraal

Health Technology

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	1
NUREXONE BIOLOGIC INC.	Health Technology

Bedrijven in privébezit	2
Silexion Therapeutics Ltd. Silexion Therapeutics Ltd. BiotechnologyHealth Technology Silenseed Ltd. operates as a biopharmaceutical company. Its programs include SiG12D-LODER for pancreatic cancer, and Prostate-LODER, GBM-LODER for brain cancer. The company was founded by Dr. Amotz Shemi and Prof. Eithan Galun on November 30, 2008 and is headquartered in Modi’in, Israel.	Health Technology
VVT Medical Ltd.